Clinical trial
An Observational Study to Assess the Effectiveness of the Standard of Care (Hydroxychloroquine+Azythromicin or Chloroquine+Azythromicin) Recommended by the Ministry of Health for the Treatment of the Coronavirus Infection in Burkina Faso
NCT04445441 is registered in ClinicalTrials.gov with Centre Muraz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Assess the Effectiveness of the Standard of Care (Hydroxychloroquine+Azythromicin or Chloroquine+Azythromicin) Recommended by the Ministry of Health for the Treatment of the Coronavirus Infection in Burkina Faso
- Lead sponsor
- Centre Muraz
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 24, 2020
- Completion date
- November 30, 2020
- Enrollment
- 153 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection